Journal for Clinical Studies Article: With huge leaps in the understanding of cancer resulting in an ever-expanding set of treatment targets, it’s an exciting, yet fiercely competitive, time to be working in oncology. Despite more people surviving the disease than ever before, a staggering 9.6 million people worldwide died from cancer in 2018, making the need for new drugs a global priority. With the search for new treatments stepping up, patient technology and systems that can improve recruitment and retention while contributing to the collection of cleaner, more compliant data are in demand. eConsent, when implemented well, has the potential to help companies rise to the challenge by removing some of the common barriers to clinical development. Co-authored by Bill Byrom and Neetu Pundir, Signant Health.
Most Recent Flipbooks
Successful Oncology Trials Need Intelligent Supply Management
Power of Mobile Technology to Optimize Patient Engagement
Power of Mobile Technology to Optimize Patient Engagement and Study Success, article, authored by Neetu Pundir, Signant Health, published in the Journal for Clinical Studies.
The Case for Integrated IRT
An integrated just-in-time interactive response technology (IRT) interface can help companies reduce the costs of maintaining adequate buffers in their clinical supply chain.
ePRO for the Modern Trial: Considerations to Implementing a BYOD or Partial Provisioning Strategy
Improving Outcomes in Diabetes Research
Leveraging Technology to Develop New Trial Endpoints
eConsent Regulatory Myths_PME_NPundir
Optimizing Outcomes - Reduce the Burden of Data Collection - Oncology
An IRB Perspective on Improving Informed Consent
What the Future Holds for Informed Consent
Recruitment & Retention: Breaking Down the Barriers to eConsent Adoption
In Pursuit of eConsent: Best Practice Recommendations for Successful Integration
eConsent: 5 Key Areas of Preparation
Using eConsent in Clinical Research to Support Patient Understanding and Welfare
Successful Adoption of eConsent Best Practices for Integrating eConsent Technology
How Integrated Technology Benefits Patients and Investigators in Diabetes Clinical Trials